Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00260039
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
TPI | 4-CARBAMOYL-4-{[6-(DIFLUORO-PHOSPHONO- METHYL)-NAPHTHALENE-2-CARBONYL]- AMINO}-BUTYRIC ACID | A | 1BZC | 0.78 | |
RL2 | N-[3-CARBOXY-2-HYDROXY-PROPIONYL]- L-HOMOPHENYLALANYL-AMINO-2-METHYLBUTANE | A | 1EWM | 0.71 | |
VRG | N~2~-acetyl-N~5~-[N-(methylcarbamoyl)carbamimidoyl]- L-ornithyl-N-methyl-L-phenylalanyl- L-aspartic acid | A,B | 3CHE | 0.71 | |
SBD | D-NAPHTHYL-1-ACETAMIDO BORONIC ACID ALANINE | A | 3VSB | 0.79 | |
MEL | [((1R)-2-{(2S)-2-[({4-[AMINO(IMINO)METHYL]BENZYL}AMINO)CARBONYL]AZETIDINYL}- 1-CYCLOHEXYL-2-OXOETHYL)AMINO]ACETIC ACID | H,I | 1K22 | 0.73 | |
MEL | [((1R)-2-{(2S)-2-[({4-[AMINO(IMINO)METHYL]BENZYL}AMINO)CARBONYL]AZETIDINYL}- 1-CYCLOHEXYL-2-OXOETHYL)AMINO]ACETIC ACID | A | 1K1P | 0.73 | |
RPR | A | 1F0U | 0.7 | ||
RPR | A | 1EZQ | 0.7 | ||
33U | beta-phenyl-D-phenylalanyl-N-(4- carbamimidoylbenzyl)-L-prolinamide | H,I | 2ZO3 | 0.72 | |
KAF | N-{(5S)-4,4-dihydroxy-6-phenyl- 5-[(phenylcarbonyl)amino]hexanoyl}- L-phenylalanine | A | 3BKK | 0.76 | |
LP1 | 4-[2-(2-ACETYLAMINO-3-NAPHTALEN- 1-YL-PROPIONYLAMINO)-4-METHYL-PENTANOYLAMINO]- 3-HYDROXY-6-METHYL-HEPTANOIC ACID [1- (1-CARBAMOYL-2-NAPHTHALEN-1-YL- ETHYLCARBAMOYL)-PROPYL]-AMIDE | A | 4FIV | 0.74 | |
LP1 | 4-[2-(2-ACETYLAMINO-3-NAPHTALEN- 1-YL-PROPIONYLAMINO)-4-METHYL-PENTANOYLAMINO]- 3-HYDROXY-6-METHYL-HEPTANOIC ACID [1- (1-CARBAMOYL-2-NAPHTHALEN-1-YL- ETHYLCARBAMOYL)-PROPYL]-AMIDE | A | 1ODY | 0.74 | |
LP1 | 4-[2-(2-ACETYLAMINO-3-NAPHTALEN- 1-YL-PROPIONYLAMINO)-4-METHYL-PENTANOYLAMINO]- 3-HYDROXY-6-METHYL-HEPTANOIC ACID [1- (1-CARBAMOYL-2-NAPHTHALEN-1-YL- ETHYLCARBAMOYL)-PROPYL]-AMIDE | A | 2FMB | 0.74 | |
Q50 | {(1S)-1-BENZYL-4-[3-CARBAMOYL-1- (1-CARBAMOYL-2-PHENYL-ETHYLCARBAMOYL)- (S)-PROPYLCARBAMOYL]-2-OXO-5-PHENYL- PENTYL}-CARBAMIC ACID TERT-BUTYL ESTER | A,B | 1IZI | 0.71 | |
Q50 | {(1S)-1-BENZYL-4-[3-CARBAMOYL-1- (1-CARBAMOYL-2-PHENYL-ETHYLCARBAMOYL)- (S)-PROPYLCARBAMOYL]-2-OXO-5-PHENYL- PENTYL}-CARBAMIC ACID TERT-BUTYL ESTER | B | 1IZH | 0.71 | |
SMK | (3S,6S,7R,9aS)-6-{[(2S)-2-aminobutanoyl]amino}- 7-(2-aminoethyl)-N-(diphenylmethyl)- 5-oxooctahydro-1H-pyrrolo[1,2-a]azepine- 3-carboxamide | A,B | 3EYL | 0.71 | |
32U | D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}- L-prolinamide | H,I | 2ZDA | 0.7 | |
MRT | (5R,9S,12S,15S,18S,21S)-21-benzyl- 12,18-bis(carboxymethyl)-15-cyclohexyl- 1-(9H-fluoren-9-yl)-4-methyl-9- (2-methylpropyl)-3,6,10,13,16,19- hexaoxo-5-phenyl-2-oxa-4,8,11,14,17,20- hexaazadocosan-22-oic acid | A | 2ZLG | 0.73 | |
SRD | D-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID | B,C | 4VGC | 0.73 | |
FNH | (2R)-({N-[(3S)-3-({[(3S,6S)-6-CYCLOHEXYL- 5,8-DIOXO-4,7-DIAZABICYCLO[14.3.1]ICOSA- 1(20),16,18-TRIEN-3-YL]CARBONYL}AMINO)- 2-OXOHEXANOYL]GLYCYL}AMINO)(PHENYL)ACETIC ACID | A,C | 2A4Q | 0.75 | |
TI3 | [(2S)-2-SULFANYL-3-PHENYLPROPANOYL]- GLY-(5-PHENYLPROLINE) | A | 1QF2 | 0.73 | |
821 | A | 1O43 | 0.73 | ||
PZQ | PRAZIQUANTEL | A | 1GTB | 0.74 | |
SBL | L-NAPHTHYL-1-ACETAMIDO BORONIC ACID ALANINE | A | 1AV7 | 0.79 | |
K7J | N-(3-carboxypropanoyl)-L-alanyl- L-alanyl-N-[(1S,2R)-1-benzyl-2- hydroxypropyl]-L-prolinamide | A | 2QXI | 0.72 | |
K7J | N-(3-carboxypropanoyl)-L-alanyl- L-alanyl-N-[(1S,2R)-1-benzyl-2- hydroxypropyl]-L-prolinamide | A | 2QXH | 0.72 | |
K7J | N-(3-carboxypropanoyl)-L-alanyl- L-alanyl-N-[(1S,2R)-1-benzyl-2- hydroxypropyl]-L-prolinamide | A | 2QXJ | 0.72 | |
51U | D-phenylalanyl-N-(3-methylbenzyl)- L-prolinamide | H,I | 2ZF0 | 0.76 | |
822 | N-ACETYL-N-[1-(1,1'-BIPHENYL-4- YLMETHYL)-2-OXOAZEPAN-3-YL]-4-[DIFLUORO(PHOSPHONO)METHYL]PHENYLALANINAMIDE | A | 1O47 | 0.72 | |
HU2 | (2S)-({N-[(3S)-3-({N-[(2S,4E)-2- ISOPROPYL-7-METHYLOCT-4-ENOYL]- L-LEUCYL}AMINO)-2-OXOHEXANOYL]GLYCYL}AMINO)(PHENYL)ACETIC ACID | A,C | 2OC1 | 0.72 | |
53U | D-phenylalanyl-N-benzyl-L-prolinamide | H,I | 2ZFF | 0.75 | |
U15 | METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY- 3-(4-METHYLPHENYL)PROPANOYL]-D- ALANYL-D-LEUCINATE | A | 2GG8 | 0.71 | |
FD2 | N-ALPHA-(2-NAPHTHYLSULFONYL)-N(3- AMIDINO-L-PHENYLALANINYL)ISOPIPECOLINIC ACID METHYL ESTER | A | 1K1J | 0.71 | |
X22 | (3S,6S,7S,9aS)-6-{[(2S)-2-aminobutanoyl]amino}- N-(diphenylmethyl)-7-(hydroxymethyl)- 5-oxooctahydro-1H-pyrrolo[1,2-a]azepine- 3-carboxamide | A,B,C,D | 3CLX | 0.72 | |
X22 | (3S,6S,7S,9aS)-6-{[(2S)-2-aminobutanoyl]amino}- N-(diphenylmethyl)-7-(hydroxymethyl)- 5-oxooctahydro-1H-pyrrolo[1,2-a]azepine- 3-carboxamide | A,B,C,D | 3CM7 | 0.72 | |
QIX | N~2~-[(2R)-4-(HYDROXYAMINO)-2-(2- NAPHTHYLMETHYL)-4-OXOBUTANOYL]- L-ARGINYLGLYCYLGLYCINAMIDE | A,B | 3E4A | 0.72 | |
SRB | L-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID | B,C | 3VGC | 0.73 | |
OIR | N-(3-PHENYL-2-SULFANYLPROPANOYL)PHENYLALANYLALANINE | A | 1R1J | 0.73 | |
TR1 | 2-(2-{2-[(BIPHENYL-4-YLMETHYL)- AMINO]-3-MERCAPTO-PENTANOYLAMINO}- ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER | A,B | 1C8T | 0.76 | |
TR1 | 2-(2-{2-[(BIPHENYL-4-YLMETHYL)- AMINO]-3-MERCAPTO-PENTANOYLAMINO}- ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER | A,B | 1C3I | 0.76 | |
998 | N-METHYLALANYL-3-METHYLVALYL-N- (1,2,3,4-TETRAHYDRONAPHTHALEN-1- YL)PROLINAMIDE | A | 1TFQ | 0.75 | |
IAM | 4-[(ISOPROPYLAMINO)METHYL]PHENYLALANINE | A | 1XY5 | 0.73 | |
IAM | 4-[(ISOPROPYLAMINO)METHYL]PHENYLALANINE | A | 1XY8 | 0.73 | |
IAM | 4-[(ISOPROPYLAMINO)METHYL]PHENYLALANINE | A | 1XY9 | 0.73 | |
IAM | 4-[(ISOPROPYLAMINO)METHYL]PHENYLALANINE | A | 1XXZ | 0.73 | |
IAM | 4-[(ISOPROPYLAMINO)METHYL]PHENYLALANINE | A | 1XY4 | 0.73 | |
IAM | 4-[(ISOPROPYLAMINO)METHYL]PHENYLALANINE | A | 1XY6 | 0.73 | |
KEL | N-[(2R)-2-benzyl-4-(hydroxyamino)- 4-oxobutanoyl]-L-alanine | X | 3B7U | 0.71 | |
FRF | PHE-REDUCED-PHE | A,I | 1GVX | 0.73 | |
BR4 | 6-PHENYL-4(R)-(7-PHENYL-HEPTANOYLAMINO)- HEXANOIC ACID | A | 1KQU | 0.75 | |
853 | 5-[2-ACETYLAMINO-2-(1-BIPHENYL- 4-YLMETHYL-2-OXO-AZEPAN-3-YLCARBAMOYL)- ETHYL]-2-CARBOXYMETHYL-BENZOIC ACID | A | 1O48 | 0.73 | |
G23 | (2R,4S)-2-[(R)-BENZYLCARBAMOYL- PHENYLACETYL-METHYL]-5,5-DIMETHYL- THIAZOLIDINE-4-CARBOXYLIC ACID | A | 1HTE | 0.73 | |
BI6 | (3S,6S,7Z,10AS)-N-(DIPHENYLMETHYL)- 6-{[(2S)-2-(METHYLIDENEAMINO)BUTANOYL]AMINO}- 5-OXO-1,2,3,5,6,9,10,10A-OCTAHYDROPYRROLO[1,2- A]AZOCINE-3-CARBOXAMIDE | A | 2JK7 | 0.7 | |
PH0 | N-{(2S)-3-[(R)-[(1R)-1-amino-2- phenylethyl](hydroxy)phosphoryl]- 2-benzylpropanoyl}-L-phenylalanine | A | 2R59 | 0.71 | |
W22 | [(2S)-4-methyl-3-oxo-2,3,4,5-tetrahydro- 1H-1,4-benzodiazepin-2-yl]acetic acid | A,B | 2WKW | 0.75 | |
197 | 4-[2-ACETYLAMINO-2-(1-BIPHENYL- 4-YLMETHYL-2-OXO-AZEPAN-3-YLCARBAMOYL)- ETHYL]-2-FORMYL-BENZOIC ACID | A | 1O4A | 0.74 | |
FD1 | N-ALPHA-(2-NAPHTHYLSULFONYL)-N- (3-AMIDINO-L-PHENYLALANINYL)-D- PIPECOLINIC ACID | A | 1K1I | 0.72 | |
002 | N-[(2R)-2-BENZYL-4-(HYDROXYAMINO)- 4-OXOBUTANOYL]-L-ISOLEUCYL-L-LEUCINE | A,B | 2FV9 | 0.73 | |
852 | 2-{4-[2-ACETYLAMINO-2-(1-BIPHENYL- 4-YLMETHYL-2-OXO-AZEPAN-3-YLCARBAMOYL)- ETHYL]-2-CARBOXY-PHENYL}-MALONIC ACID | A | 1O44 | 0.71 | |
RAG | ARGIFIN | A,B | 1W9V | 0.71 | |
RAG | ARGIFIN | A | 1WB0 | 0.71 | |
23U | beta-phenyl-D-phenylalanyl-N-(3- chlorobenzyl)-L-prolinamide | H,I | 3DHK | 0.71 | |
HOP | (1S,2S,5S)2-(4-GLUTARIDYLBENZYL)- 5-PHENYL-1-CYCLOHEXANOL | H,L | 1D6V | 0.71 | |
HOP | (1S,2S,5S)2-(4-GLUTARIDYLBENZYL)- 5-PHENYL-1-CYCLOHEXANOL | A,B,H,L | 1AXS | 0.71 | |
DBZ | 3-(BENZOYLAMINO)-L-ALANINE | A,B,C,D | 1SN9 | 0.74 | |
DBZ | 3-(BENZOYLAMINO)-L-ALANINE | A,B | 1SNE | 0.74 | |
DBZ | 3-(BENZOYLAMINO)-L-ALANINE | A,B,C,D | 1SNA | 0.74 | |
DBZ | 3-(BENZOYLAMINO)-L-ALANINE | A,B | 1XOF | 0.74 | |
SNA | N-{1-[5-(1-CARBAMOYL-2-MERCAPTO- ETHYLCARBAMOYL)-PENTYLCARBAMOYL]- 2-[4-(DIFLUORO-PHOSPHONO-METHYL)- PHENYL]-ETHYL}-3-{2-[4-(DIFLUORO- PHOSPHONO-METHYL)-PHENYL]-ACETYLAMINO}- SUCCINAMIC ACID | A | 1PXH | 0.72 | |
BGD | N-BENZOYL-L-GLUTAMYL-[4-PHOSPHONO(DIFLUOROMETHYL)]- L-PHENYLALANINE-[4-PHOSPHONO(DIFLUORO- METHYL)]-L-PHENYLALANINEAMIDE | A,B,C,D | 1LQF | 0.71 | |
MN2 | 1-CARBOXYETHYLAMINOMETHYL-4-AMINOMETHYLBENZENE | N | 1NLO | 0.73 | |
NAL | BETA-(2-NAPHTHYL)-ALANINE | A,B | 2ITK | 0.73 | |
NAL | BETA-(2-NAPHTHYL)-ALANINE | H,I | 4THN | 0.73 | |
NAL | BETA-(2-NAPHTHYL)-ALANINE | A,B | 2Q5A | 0.73 | |
NAL | BETA-(2-NAPHTHYL)-ALANINE | A | 1ZWU | 0.73 | |
NAL | BETA-(2-NAPHTHYL)-ALANINE | A | 1SKL | 0.73 | |
NAL | BETA-(2-NAPHTHYL)-ALANINE | H,I | 5GDS | 0.73 | |
NAL | BETA-(2-NAPHTHYL)-ALANINE | A | 1ZH0 | 0.73 | |
NAL | BETA-(2-NAPHTHYL)-ALANINE | A,B | 2JT9 | 0.73 | |
GAN | 2-[3-BENZYL-5-(1-ALANYL-AMINOETHYL)- 2,3,6,7-TETRAHYDRO-1H-AZEPIN-1- YL]-1-OXOPROPYL-VALINYL-VALINE- METHYLESTER | A | 1HBV | 0.7 | |
MY5 | {1-[(3S)-4-{[(1S)-2-(BENZYLAMINO)- 1-METHYL-2-OXOETHYL]AMINO}-3-HYDROXY- 4-OXOBUTANOYL]HYDRAZINO}ACETIC ACID | I | 2CNN | 0.72 | |
BAV | (3S,14R,16S)-16-[(1R)-1-hydroxy- 2-{[3-(1-methylethyl)benzyl]amino}ethyl]- 3,4,14-trimethyl-1,4-diazacyclohexadecane- 2,5-dione | A,B,C | 3DV5 | 0.73 | |
R99 | N-[3-CARBOXY-2-HYDROXY-PROPIONYL]- D-HOMOPHENYLALANYL-AMINO-2-METHYLBUTANE | A | 1EWL | 0.71 | |
AO1 | (2S,3R)-3-AMINO-2-HYDROXY-5-(ETHYLSULFANYL)PENTANOYL- ((S)-(-)-(1-NAPHTHYL)ETHYL)AMIDE | A | 1R5G | 0.74 | |
008 | (S)-2-[(R)-3-AMINO-4-(2-FLUORO- PHENYL)-BUTYRYL]-1,2,3,4-TETRAHYDRO- ISOQUINOLINE-3-CARBOXYLIC ACID AMIDE | A,B,C,D | 2BUC | 0.78 | |
U16 | METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY- 3-(4-ISOPROPYLPHENYL)PROPANOYL]- D-ALANYL-D-LEUCINATE | A | 2GG9 | 0.71 | |
PPB | 1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)- PYRROLIDINE-2-CARBONYL]-AMINO}- 2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID | A | 1AUJ | 0.7 | |
BC1 | 3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN- 9-YL)CARBONYL]AMINO}PROPANOIC ACID | H,Y | 1LO0 | 0.72 | |
TIN | A,B | 1N94 | 0.74 | ||
UN5 | {3(S)-METHYLCARBAMOYL-2-[3-(3-SULFOAMINO- PHENYL)-PROPIONYL]-1,2,3,4-TETRAHYDRO- ISOQUINOLIN-7-YL}-SULFAMIC ACID | A | 2F6Z | 0.7 | |
F1H | N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide | A | 2ZJH | 0.7 | |
37U | D-phenylalanyl-N-(3-fluorobenzyl)- L-prolinamide | H,I | 2ZDV | 0.73 | |
LPR | [N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]- L-LYSYL-L-PROLINE | A,B | 1J36 | 0.7 | |
LPR | [N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]- L-LYSYL-L-PROLINE | A,B | 2C6N | 0.7 | |
LPR | [N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]- L-LYSYL-L-PROLINE | A | 1O86 | 0.7 | |
FA4 | SM-25453 | A,B | 2D1O | 0.7 | |
FA4 | SM-25453 | A,B | 2D1N | 0.7 | |
NAM | NAM NAPTHYLAMINOALANINE | A,B,I,J | 3FIV | 0.7 | |
NAM | NAM NAPTHYLAMINOALANINE | A,B,I,J | 2FIV | 0.7 | |
GK5 | N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)- 6-methylbiphenyl-3,4'-dicarboxamide | A | 3D7Z | 0.71 | |
S1S | 2-(4-((9S,10S,14S,Z)-18-(2-AMINO- 2-OXOETHYL)-9-(CARBOXYMETHYL)-14- (NAPHTHALEN-1-YLMETHYL)-8,17,20- TRIOXO-7,16,19-TRIAZASPIRO[5.14]ICOS- 11-EN-10-YL)PHENYL)MALONIC ACID | A,B,C,D | 2AOB | 0.77 | |
S1S | 2-(4-((9S,10S,14S,Z)-18-(2-AMINO- 2-OXOETHYL)-9-(CARBOXYMETHYL)-14- (NAPHTHALEN-1-YLMETHYL)-8,17,20- TRIOXO-7,16,19-TRIAZASPIRO[5.14]ICOS- 11-EN-10-YL)PHENYL)MALONIC ACID | A,B | 2AOA | 0.77 | |
URG | N-acetyl-D-alanyl-N~5~-[N-(methylcarbamoyl)carbamimidoyl]- L-ornithyl-N-methyl-L-phenylalanyl- L-aspartic acid | A,B | 3CHF | 0.7 | |
N4T | (1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5- DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO- 1H-PYRROL-1-YL]-2-OXOETHANAMINE | A,B | 2FL2 | 0.7 | |
NHL | (4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID | A | 2OHV | 0.72 | |
NKK | N~2~-(naphthalen-2-ylcarbonyl)- L-lysyl-N-[(1S)-4-carbamimidamido- 1-formylbutyl]-L-lysinamide | B,D | 3E90 | 0.71 | |
M1N | (1R)-3-METHYL-1-{[N-(MORPHOLIN- 4-YLCARBONYL)-3-(1-NAPHTHYL)-D- ALANYL]AMINO}BUTYLBORONIC ACID | 2,C,E,G,H,J, L,N,P,R,T,V, X,Z | 2FHH | 0.75 | |
ALN | NAPHTHALEN-2-YL-3-ALANINE | A,B,I,J | 2FIV | 0.71 | |
ALN | NAPHTHALEN-2-YL-3-ALANINE | A,B | 1B0H | 0.71 | |
ALN | NAPHTHALEN-2-YL-3-ALANINE | B | 1FIV | 0.71 | |
ALN | NAPHTHALEN-2-YL-3-ALANINE | A,B,I,J | 3FIV | 0.71 | |
DTF | 4-[(10S,14S,18S)-18-(2-AMINO-2- OXOETHYL)-14-(1-NAPHTHYLMETHYL)- 8,17,20-TRIOXO-7,16,19-TRIAZASPIRO[5.14]ICOS- 11-EN-10-YL]BENZYLPHOSPHONIC ACID | A | 1X0N | 0.73 | |
27U | N-(4-carbamimidoylbenzyl)-1-(3- phenylpropanoyl)-L-prolinamide | H,I | 2ZHQ | 0.7 | |
MY1 | [N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)- HYDRAZINO]-ACETIC ACID | I | 2CDR | 0.7 | |
F1K | (2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine- 2-carboxamide | A,B,C | 2ZJK | 0.71 | |
876 | N-ACETYL-N-[1-(1,1'-BIPHENYL-4- YLMETHYL)-2-OXOAZEPAN-3-YL]-3,4- DIPHOSPHONOPHENYLALANINAMIDE | A | 1O4B | 0.73 | |
HPI | N-(1-CARBOXY-3-PHENYLPROPYL)PHENYLALANYL- ALPHA-ASPARAGINE | A | 1U4G | 0.8 | |
MMI | N-[(4S,5S,7R)-8-({(S)-1-[(BENZYLAMINO)OXOMETHYL]- 2-METHYLPROPYL}AMINO)-5-HYDROXY- 2,7-DIMETHYL-8-OXO-OCT-4-YL]-(4S,7S)- 4-ISOPROPYL-2,5,9-TRIOXO-1-OXA- 3,6,10-TRIAZACYCLOHEXADECANE-7- CARBOXAMIDE | D | 1XS7 | 0.72 | |
NPG | N-SUCCINYL PHENYLGLYCINE | A,B,C,D | 1SJD | 0.74 | |
X23 | (3S,6S,7R,9aS)-6-{[(2S)-2-aminobutanoyl]amino}- 7-(aminomethyl)-N-(diphenylmethyl)- 5-oxooctahydro-1H-pyrrolo[1,2-a]azepine- 3-carboxamide | A,B,C,D,E,F, G,H,I,J | 3CM2 | 0.71 | |
F1J | (2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine- 2-carboxamide | A | 2ZJJ | 0.71 | |
MNO | (3S)-N-METHANESULFONYL-3-({1-[N- (2-NAPHTOYL)-L-VALYL]-L-PROLYL}AMINO)- 4-OXOBUTANAMIDE | A | 1BMQ | 0.71 | |
44U | beta-phenyl-D-phenylalanyl-N-propyl- L-prolinamide | B,D | 3DA9 | 0.72 | |
ALR | ALRESTATIN | A | 1AZ1 | 0.73 | |
JNH | 1-[2-(S)-AMINO-3-BIPHENYL-4-YL- PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE | I,J | 2AJL | 0.72 | |
PME | N-L-ALPHA-ASPARTYL L-PHENYLALANINE 1- METHYL ESTER | H,L | 1A8J | 0.75 | |
GA0 | GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE | A | 2DCM | 0.72 | |
LGG | N-ACETYL-L-ALPHA-GLUTAMYL-L-PHENYLALANYL- L-GLUTAMINYL-N-[(1S)-4-AMINO-1- (2-CARBOXYETHYL)-4-OXOBUTYL]-L- LEUCINAMIDE | A,B | 2IPH | 0.7 | |
GGC | 1-MENAPHTHYL GLUTATHIONE CONJUGATE | A,B | 3LJR | 0.76 | |
BIR | N-[3-[(1-AMINOETHYL)(HYDROXY)PHOSPHORYL]- 2-(1,1'-BIPHENYL-4-YLMETHYL)PROPANOYL]ALANINE | A | 1R1H | 0.71 | |
BIR | N-[3-[(1-AMINOETHYL)(HYDROXY)PHOSPHORYL]- 2-(1,1'-BIPHENYL-4-YLMETHYL)PROPANOYL]ALANINE | L | 3B7R | 0.71 | |
TI1 | [2(R,S)-2-SULFANYLHEPTANOYL]-PHE- ALA | A | 1R1I | 0.71 | |
TI1 | [2(R,S)-2-SULFANYLHEPTANOYL]-PHE- ALA | A | 1QF1 | 0.71 |